As a platform company developing drugs against a newly identified class of enzymes, Nitrome Biosciences will have found and characterized this class of enzymes and will have paved a novel inroad into the proprietary development of disease-modifying therapies. They are initially targeting Parkinson’s disease and developing cures for multiple aging-dependent diseases, including other neurodegenerative diseases, Type II diabetes, heart disease, and cancer.

Biotechnology

Nitrome Biosciences

Irene Griswold-Prenner

Sarah Wright

Frank Kayser

Arun Kashyap

Carla Ramos

Gary Probst

Sami Hussain

Scientific Team

Leadership Team

Teams at Nitrome Biosciences

Scientific Team

Leadership Team